Varenicline rescues nicotine-induced decrease in motivation for sucrose reinforcement
Copyright © 2020 Elsevier B.V. All rights reserved..
Varenicline is one of the top medications used for smoking cessation and is often prescribed before termination of nicotine use. The effect of this combined nicotine and varenicline use on the reward system and motivation for primary reinforcement is underexplored. The goal of this study was to assess the effects of nicotine and varenicline on motivation for a food reinforcer. In Experiment 1, we first assessed the responding for sucrose after pretreatment with nicotine (0, 0.1, or 0.4 mg/kg) and varenicline (0.0, 0.1, 1.0 mg/kg) using a behavioral economics approach. The responding for sucrose was then assessed using a progressive ratio schedule of reinforcement after pretreatment with all possible combinations of nicotine and varenicline doses. In Experiment 2, rats were assessed for the consumption of sucrose in home cages after pretreatment with nicotine and varenicline. We found that (a) nicotine decreased economic demand for sucrose, (b) varenicline rescued nicotine-induced reduction in economic demand for sucrose, and (c) history of varenicline treatment predicted responding for sucrose on a progressive ratio schedule of reinforcement where rats with a history of varenicline treatment responded significantly lower for sucrose across nicotine doses than rats that had not been exposed to varenicline. The results of Experiment 2 largely confirmed that nicotine decreases motivation for sucrose using a passive consumption protocol and that varenicline rescues this effect. Overall, these findings suggest that varenicline interacts with the effects of nicotine by restoring nicotine-induced reduction in motivation for appetitive rewards.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:397 |
|---|---|
| Enthalten in: |
Behavioural brain research - 397(2021) vom: 15. Jan., Seite 112887 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hart, Erin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
57-50-1 |
|---|
| Anmerkungen: |
Date Completed 15.11.2021 Date Revised 16.01.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.bbr.2020.112887 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315037539 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315037539 | ||
| 003 | DE-627 | ||
| 005 | 20231225154038.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bbr.2020.112887 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1050.xml |
| 035 | |a (DE-627)NLM315037539 | ||
| 035 | |a (NLM)32931838 | ||
| 035 | |a (PII)S0166-4328(20)30586-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hart, Erin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Varenicline rescues nicotine-induced decrease in motivation for sucrose reinforcement |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.11.2021 | ||
| 500 | |a Date Revised 16.01.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier B.V. All rights reserved. | ||
| 520 | |a Varenicline is one of the top medications used for smoking cessation and is often prescribed before termination of nicotine use. The effect of this combined nicotine and varenicline use on the reward system and motivation for primary reinforcement is underexplored. The goal of this study was to assess the effects of nicotine and varenicline on motivation for a food reinforcer. In Experiment 1, we first assessed the responding for sucrose after pretreatment with nicotine (0, 0.1, or 0.4 mg/kg) and varenicline (0.0, 0.1, 1.0 mg/kg) using a behavioral economics approach. The responding for sucrose was then assessed using a progressive ratio schedule of reinforcement after pretreatment with all possible combinations of nicotine and varenicline doses. In Experiment 2, rats were assessed for the consumption of sucrose in home cages after pretreatment with nicotine and varenicline. We found that (a) nicotine decreased economic demand for sucrose, (b) varenicline rescued nicotine-induced reduction in economic demand for sucrose, and (c) history of varenicline treatment predicted responding for sucrose on a progressive ratio schedule of reinforcement where rats with a history of varenicline treatment responded significantly lower for sucrose across nicotine doses than rats that had not been exposed to varenicline. The results of Experiment 2 largely confirmed that nicotine decreases motivation for sucrose using a passive consumption protocol and that varenicline rescues this effect. Overall, these findings suggest that varenicline interacts with the effects of nicotine by restoring nicotine-induced reduction in motivation for appetitive rewards | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Economic demand | |
| 650 | 4 | |a Nicotine | |
| 650 | 4 | |a Nicotine cessation | |
| 650 | 4 | |a Nicotine use | |
| 650 | 4 | |a Varenicline | |
| 650 | 7 | |a Nicotinic Agonists |2 NLM | |
| 650 | 7 | |a Smoking Cessation Agents |2 NLM | |
| 650 | 7 | |a Sucrose |2 NLM | |
| 650 | 7 | |a 57-50-1 |2 NLM | |
| 650 | 7 | |a Nicotine |2 NLM | |
| 650 | 7 | |a 6M3C89ZY6R |2 NLM | |
| 650 | 7 | |a Varenicline |2 NLM | |
| 650 | 7 | |a W6HS99O8ZO |2 NLM | |
| 700 | 1 | |a Hertia, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Barrett, Scott T |e verfasserin |4 aut | |
| 700 | 1 | |a Charntikov, Sergios |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Behavioural brain research |d 1993 |g 397(2021) vom: 15. Jan., Seite 112887 |w (DE-627)NLM012632252 |x 1872-7549 |7 nnns |
| 773 | 1 | 8 | |g volume:397 |g year:2021 |g day:15 |g month:01 |g pages:112887 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bbr.2020.112887 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 397 |j 2021 |b 15 |c 01 |h 112887 | ||